A61K 31/26
Cyanate or isocyanate esters
Official title: Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
A61K31/26 (Cyanate or isocyanate esters) appears on 259 US grants and 451 published applications in this corpus.
Search patents in A61K- Granted patents
- 259
- Published applications
- 451
- Assignees
- 209
- Inventors
- 644
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 3 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 3 | 0 |
| 1996 | 3 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 4 | 7 |
| 2003 | 0 | 2 |
| 2004 | 3 | 4 |
| 2005 | 2 | 5 |
| 2006 | 0 | 7 |
| 2007 | 0 | 3 |
| 2008 | 2 | 9 |
| 2009 | 0 | 9 |
| 2010 | 1 | 13 |
| 2011 | 4 | 9 |
| 2012 | 6 | 17 |
| 2013 | 7 | 25 |
| 2014 | 13 | 16 |
| 2015 | 7 | 27 |
| 2016 | 13 | 32 |
| 2017 | 22 | 28 |
| 2018 | 21 | 26 |
| 2019 | 20 | 29 |
| 2020 | 25 | 26 |
| 2021 | 10 | 41 |
| 2022 | 25 | 20 |
| 2023 | 19 | 39 |
| 2024 | 13 | 27 |
| 2025 | 7 | 20 |
| 2026 | 6 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for improving physical exercise performance18 Aug 2026US 12,708,613 B2Nomio Nutrition AB
- Compositions and methods for cellular ageing, stress resilience, autophagy, inflammation and longevity4 Aug 2026US 12,697,340 B2JUVN3 Holdings, LLC
- Compositions comprising sulforaphane or a sulforaphane precursor and Moringa plant components9 Jun 2026US 12,648,979 B2Nutramax Laboratories, Inc.
- Recognition ability improving agent19 May 2026US 12,629,349 B2Kinjirushi Co., Ltd.
- Lactobacillus plantarum ZUST49 and bacterial agent, and use thereof14 Apr 2026US 12,599,640 B2Zhejiang University of Science and Technology
- Protecting a bioactive and/or precursor thereof24 Sep 2026US 2026/0283969 A1Commonwealth Scientific and Industrial Research Organisation
- Compositions comprising sulforaphane or a sulforaphane precursor and moringa plant components24 Sep 2026US 2026/0284129 A1Nutramax Laboratories, Inc.
- Short acting phenylalkylamine calcium channel blockers and uses thereof25 Jun 2026US 2026/0174722 A1Milestone Pharmaceuticals Inc.
- Composition for enhancing adrenomedullin gene expression28 May 2026US 2026/0144780 A1House Wellness Foods Corporation
- Compositions comprising sulforaphane or a sulforaphane precursor and a milk thistle extract or powder7 May 2026US 2026/0124284 A1Nutramax Laboratories, Inc.
Most cited
By later US patents
- Treatment of newborn jaundice100US 5,589,504 AAlbert Einstein College of Medicine of Yeshiva University, a Division of Yeshiva University · 1996
- Chemoprotective isothiocyanates86US 5,411,986 AThe Johns Hopkins University · 1995
- Method of inhibiting lung tumors, arylalkyl isothiocyanates, and method of synthesizing same67US 5,114,969 AAmerican Health Foundation · 1992
- Horseradish preparation for the treatment of nasal and sinus dysfunction65US 5,385,734 AHorseradish Spray, Inc. · 1995
- Treatment of helicobacter with isothiocyanates65US 6,737,441 B22004